NCT06899165View on ClinicalTrials.gov

Psilocybin-Assisted Therapy for Intergenerational Trauma

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 28, 2025

Primary Completion Date

May 31, 2029

Study Completion Date

January 2, 2030

Conditions
Psychological StressDepressionAnxiety
Interventions
DRUG

Psilocybin

Psilocybin 25mg, capsules taken orally under the supervision of two trained study therapists

BEHAVIORAL

Integration sessions

weekly integration sessions (therapy) for 6 weeks

Trial Locations (1)

10025

RECRUITING

The Parsons Research Center for Psychedelic Healing, New York

All Listed Sponsors
lead

Rachel Yehuda

OTHER

NCT06899165 - Psilocybin-Assisted Therapy for Intergenerational Trauma | Biotech Hunter | Biotech Hunter